Angelini Fine Chemicals is expanding its catalytical hydrogenation capacity with two reactors

Slide02
  • Published: 6 Jul 2021

Angelini Fine Chemicals, Business Unit of Angelini Pharma, specialized in the production of active pharmaceutical ingredients, has installed two reactors for catalytic hydrogenation in the Aprilia (LT) plant in Italy, that will expand our capability to increase the production capacity of active pharmaceutical ingredients (API).

This investment makes it possible to integrate the already technologically advanced platform dedicated to fine chemistry with two new reactors for catalytic hydrogenation - one within the Optimization Process Industrial laboratory and one for Kilo-Size activities. - to complete the production portfolio. Angelini Fine Chemicals has invested a lot in Flow Chemistry to use this method in the industrial production of active ingredients.